HSCA Response to the Centers for Medicare & Medicaid Services Request for Information on Pharmacy Benefit Manager Compensation and Data Collection
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading
traditional healthcare group purchasing organizations (GPOs), we appreciate the opportunity to provide
comments to the Centers for Medicare and Medicaid Services (CMS) regarding pharmacy benefit manager (PBM) business practices.
Click here to view the full response.
Learn MoreHSCA Applauds House Energy and Commerce Committee and Senate HELP Committee for Advancing Bipartisan Biosimilars Legislation that Will Help Increase Access to Safe Medications
Washington, D.C. (July 29, 2026) – The Healthcare Supply Chain Association (HSCA) and its traditional healthcare group purchasing organization (GPO) members commend the U.S. House Committee on Energy and Commerce for unanimously advancing two bipartisan bills that would expand patient access to lower-cost biosimilars: the Expedited Access to Biosimilars Act (H.R. 9661), led by Reps. Nick...
Learn MoreHSCA Applauds Ongoing Bipartisan Efforts that Increase Supply Chain Transparency
The Healthcare Supply Chain Association (HSCA) and its traditional healthcare group purchasing organization (GPO) members applaud the ongoing bipartisan Congressional efforts to increase healthcare supply chain transparency for the ultimate benefit of patients. Specifically, we support two bipartisan drug supply chain transparency measures: the Drug Origin Transparency Act, sponsored by Rep....
Learn MoreHSCA Response to the U.S. Trade Representative’s Section 301 Investigation of Acts, Policies, and Practices of Certain Economies Relating to Structural Excess Capacity and Production in Manufacturing Sectors
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading traditional healthcare group purchasing organizations (GPOs), we appreciate the opportunity to provide comments to the Office of the U.S. Trade Representative on its Section 301 investigation into structural excess capacity and production in manufacturing sectors.
Click here to view the...
Learn MoreHSCA Comments on the Centers for Medicare & Medicaid Services Advance Notice of Proposed Rulemaking on Ensuring Safety Through Domestic Security With Made in America PPE and Essential Medicine Procurement by Medicare Participating Hospitals
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading traditional healthcare group purchasing organizations (GPOs), we appreciate the opportunity to provide comments to the Centers for Medicare and Medicaid Services (CMS) regarding its Advance Notice of Proposed Rulemaking (ANPRM) on Ensuring Safety Through Domestic Security With Made in...
Learn MoreTestimony of HSCA CEO Angie Boliver before the Subcommittee on Health, House Committee on Energy and Commerce
Thank you for the opportunity to discuss the important role of traditional healthcare group purchasing organizations (GPOs) in lowering costs in the pharmaceutical supply chain.
Click here to view the full response.
Learn MoreHSCA Response to the U.S. Department of Commerce’s Section 232 National Security Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment and Devices
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading traditional healthcare group purchasing organizations (GPOs), we appreciate the opportunity to provide comments to the U.S. Department of Commerce on its Section 232 national security investigation into imports of personal protective equipment (PPE), medical consumables, and medical equipment and...
Learn More